Alterations in the neuromuscular system underlie several neuromuscular diseases and play critical roles in the development of sarcopenia, the age-related loss of muscle mass and function. Mammalian Myostatin (MST) and GDF11, members of the TGF-β superfamily of growth factors, are powerful regulators of muscle size in both model organisms and humans. Myoglianin (MYO), the Drosophila homolog of MST and GDF11, is a strong inhibitor of synaptic function and structure at the neuromuscular junction (NMJ), and a negative regulator of body weight and muscle size and function in flies. Here, we identified Plum, a cell surface immunoglobulin homologous to mammalian developmental regulators Protogenin and Nope, as a modulator of MYO function in the larval neuromuscular system. Reduction of Plum specifically in the larval body-wall muscles abolishes the previously demonstrated positive effect of attenuated MYO signalling on both muscle size and neuromuscular junction structure and function, likely by de-sequestrating the remaining MYO. In addition, downregulation of Plum on its own results in decreased synaptic strength and body weight, classifying Plum as a (novel) regulator of neuromuscular function and body (muscle) size. These findings offer new insights into possible regulatory mechanisms behind ageing-and disease-related neuromuscular dysfunctions in humans and identify potential targets for therapeutic interventions.
INTRODUCTION
The neuromuscular system is comprised of individual motor units, each consisting of a single motor neuron, a neuromuscular junction and all the muscle fibres innervated by the motor neuron. Diminished motor unit function and decreased muscle volume are hallmarks of several neuromuscular disorders (Gonzalez-Freire et al., 2014) and of sarcopenia, the age-associated loss of skeletal muscle mass and function (Cruz-Jentoft et al., 2010) . Gradual loss of skeletal muscle capacity has been reported in invertebrates, rodents, and humans (Eddinger et al., 1985; Herndon et al., 2002; Young et al., 1985) , with the intrinsic mechanisms regulating age-related muscle dysfunction largely conserved across species (Demontis et al., 2013) . Age-related muscle loss is accompanied by progressive modifications in the structure and function of the neuromuscular junction (NMJ), the specialised synapse at the interface between the nervous and muscular system (Gonzalez-Freire et al., 2014) , with the resulting uncoupling of the excitation-contraction machinery (Delbono, 2000; Delbono et al., 1995) . In mammals, including humans, these modifications include changes in the branching pattern of the motor nerve terminal that contacts the myofiber, fragmented NMJ architecture, impaired synaptic acetylcholine receptor distribution, and decreased density of presynaptic active zone markers (Barker and Ip, 1966; Chen et al., 2012; Nishimune et al., 2016; Oda, 1984; Wokke et al., 1990) . Functionally, aged mammalian NMJs exhibit increased failures in evoked release (Lee et al., 2017) , changes in quantal release (Kelly and Robbins, 1983 ) and a slowing-down of axoplasmic transport of proteins (Gutmann and Hanzlikova, 1973) . Skeletal muscle and NMJ deficits are found in many motoneuronal and neuromuscular disorders, with impaired neurotransmission and muscle wasting characterising amyotrophic lateral sclerosis (ALS) (Cappello and Francolini, 2017; Chand et al., 2018; Pansarasa et al., 2014) , myotonic and muscular dystrophies (Bombelli et al., 2016; Malatesta, 2012; Mateos-Aierdi et al., 2015; Rudolf et al., 2014; Shin et al., 2013) , myasthenia gravis (Fambrough et al., 1973; Shigemoto et al., 2010) and others. Whether muscle loss precedes or follows the changes in the function of the NMJ is currently unresolved, but animals studies suggest that NMJ remodelling might play a critical role in the progression of sarcopenia (Ezaki et al., 2000) .
Drosophila melanogaster is a convenient and proven model system for studying various aspects of developmental regulation of muscle mass and control of NMJ function (Augustin and Partridge, 2009; Kreipke et al., 2017; Plantie et al., 2015) . Drosophila larval glutamatergic NMJs share structural and functional similarities with mammalian cholinergic junctions (Budnik, 1996) and striated muscles in Drosophila resemble vertebrate skeletal muscles in structure, function, and protein composition (Augustin and Partridge, 2009) . Previously, we used this model system to investigate the role of Drosophila MYO, the muscle-and glia-expressed fly homolog of TGF-β growth factors Myostatin (MST) and GDF11 (Lo and Frasch, 1999) , in regulating synaptic function, muscle size and body weight (Augustin et al., 2017) . MST (also known as GDF-8) is a circulating cytokine that serves as a powerful negative regulator of muscle mass in mammalian species (Carnac et al., 2007; McPherron et al., 1997) . In addition to its MST-like role as an inhibitor of larval weight and muscle size, muscle-derived MYO is a strong negative regulator of neurotransmission, synaptic morphology and the density of critical pre-and post-synaptic components (Augustin et al., 2017) .
Plum is a Drosophila transmembrane, immunoglobulin superfamily protein (Yu et al., 2013) and a distant homolog of Protogenin and Nope, mammalian regulators of developmental processes in nervous, muscle and epithelial tissues (Salbaum and Kappen, 2000; Takahashi et al., 2010; Wong et al., 2010) . Protogenin was also associated with attention deficit hyperactivity disorder (Wigg et al., 2008) and Nope is a surface marker for human and murine liver cancers (Marquardt et al., 2011; Xiang et al., 2016) . Recently, Plum was identified as a modulator of axon pruning in the Drosophila nervous system (Yu et al., 2013) . Plum genetically interacts and interferes with MYO function, likely by physically sequestrating MYO (Yu et al., 2013) . In this study, we examined the interactions between Plum and MYO in regulating larval muscles and NMJ physiology. We identified Plum as a novel modulator of MYO action on NMJ synaptic transmission and muscle size, and an independent regulator of synaptic strength and larval weight.
RESULTS

Muscle-derived Plum regulates NMJ synapse strength independently and by modulating MYO
We previously showed that genetic attenuation of Myo specifically in the larval somatic muscle, using a microRNA construct to target the Myo transcript (genotype: Mef2-GAL4/UAS-miRNAmyo) (Awasaki et al., 2011) , increases muscle size, NMJ synaptic transmission and locomotion by >20% (Augustin et al., 2017) , defining MYO as a potent neuromuscular inhibitor in flies. Considering the large size of the (postsynaptic) muscle compartment relative to the (presynaptic) motoneuronal and glial compartments, and the expression of the Plum mammalian homolog Nope in developing skeletal muscles (Salbaum and Kappen, 2000) , we investigated interactions between Plum and MYO by knocking-down Plum in the larval body-wall muscle. We therefore analysed phenotypes in double knock-down MYO-Plum larvae (Mef2-GAL4/UAS-miRNAmyo/plumRNAi) and single knock-down Plum animals (Mef2-GAL4/UAS-plumRNAi).
We first examined the impact of Plum down-regulation on NMJ physiology. Body-wall muscles in developing flies consist of bilaterally symmetrical hemi-segments composed of 30 multinucleated muscle fibres (Ruiz-Canada and Budnik, 2006) . We focused our analyses on muscles 6 and 7, large myofibres innervated by two motoneurons forming a single, excitatory, chemical (glutamatergic) NMJ. Contractions of these muscles are triggered by "non-spiking" postsynaptic potentials that are graded in duration and amplitude, allowing for quantitative comparisons between genotypes (Peron et al., 2009) . The amplitude of these Ca 2+ -dependent, nerve-evoked postsynaptic excitatory junctional currents (eEJCs) reflects either the magnitude of presynaptic release or the postsynaptic sensitivity to neurotransmitter (Peron et al., 2009 ). Muscle-specific reduction of MYO leads to dramatically increased evoked response (Augustin et al., 2017) ; simultaneous suppression of Plum, however, reversed the response to control (+Mef2-GAL4) levels, with the down-regulation of Plum alone further diminishing the evoked currents. Further examination of the data showed a statistically significant interaction between the effects of simultaneously reduced MYO and Plum relative to the control genotype (two-way ANOVA analysis in Fig. 1B) . We then measured the amplitudes of spontaneous "miniature" postsynaptic currents (mEJCs), also known as "quantal size" (Petersen et al., 1997) . The mEJCs represent postsynaptic responses to a single presynaptically released vesicle containing neurotransmitter and are a reliable indicator of the density of functional, NMJ, glutamate receptors (DiAntonio et al., 1999) . While the mean mEJC amplitude did not differ significantly between genotypes ( Figs. 1A and 1C) , the frequency distribution analysis revealed that Plum down-regulation in either control or reduced MYO background caused a strong shift toward smaller "miniature" currents ( Fig. 1D) . The number of presynaptic release sites or probability of spontaneous vesicle fusion events was not affected, as demonstrated by the normal mEJC frequency in mutant genotypes ( Fig. 1E) . Taken together, our electrophysiological results imply that MYO and Plum affect NMJ physiology by controlling the density of the postsynaptic glutamate receptor field, with Plum having a modulatory effect on MYO and acting as an autonomous synaptic regulator.
Figure 1 (next page). Plum is a regulator of neurotransmission at the larval NMJ. (A)
Representative traces of evoked (top) and spontaneous ("miniature") synaptic responses recorded from muscle 6. Histograms of evoked (B) and spontaneous (C) responses for given genotypes (control: +/Mef2-GAL4; MYO downregulation: Mef2-GAL4/UAS-miRNAmyo; MYO and Plum down-regulation: Mef2-GAL4/UAS-miRNAmyo/plumRNAi; Plum down-regulation: Mef2-GAL4/UAS-plumRNAi) (n = 7-16). Two-way ANOVA analysis: the interaction between Mef2-GAL4/UAS-miRNAmyo and Mef2-GAL4/UAS-miRNAmyo/plumRNAi is highly significant (P<0.0001). (D) Cumulative frequency distribution diagram of mEJC amplitudes. Black arrow indicates shift toward higher amplitude "minis", orange toward lower. For all paired analyses except between Mef2-GAL4/UAS-miRNAmyo/plumRNAi and Mef2-GAL4/UAS-plumRNAi KS test, P<0.0001 (n=7-18 animals, ∼1500-2000 events measured per genotype). (E) Histogram of mEJC frequencies (n = 7-13). Bar graphs: error bars indicate SEM (one-way ANOVA + Tukey's post-test: *p < 0.05, ***p < 0.001, n.s. = not significant).
Plum modulates the action of MYO on synapse structure and receptor composition
Postsynaptic receptors at the larval NMJ are AMPA-type tetrameric complexes formed by glutamate receptor (GluR) subunits IIC, IID and IIE, in addition to either subunit IIA or IIB (Featherstone et al., 2005; Qin et al., 2005) . Assemblies containing the IIA subunit (GluRIIA) are pharmacologically and biophysically distinct from the ones incorporating GluRIIB and carry the bulk of the ionic current at this synapse (DiAntonio et al., 1999; Petersen et al., 1997) . We have recently shown that elevated evoked and spontaneous synaptic currents in "low MYO" larvae show corresponding increase in the density of GluRIIA receptors (Augustin et al., 2017) , in line with previously demonstrated correlation between GluRIIA levels and either evoked response (Sigrist et al., 2002) or quantal size (DiAntonio et al., 1999) . We therefore used immunohistochemistry to measure the area of GluRIIA clusters in the NMJ boutons ( Fig. 2A ) of control and mutant animals. The GluRIIA cluster area is directly proportional to the number of functional GluRs measured electrophysiologically, and independent of changes in NMJ morphology (Featherstone et al., 2002; Liebl and Featherstone, 2008; Rasse et al., 2005) .
Our results showed that Plum down-regulation in the muscle led to significantly (~20%) smaller GluRIIA clusters in animals with muscle-reduced Myo expression ( Figs. 2A-B ). This reduction was identical in magnitude to the increase in the density of IIA-type receptors upon MYO downregulation relative to the control genotype (Augustin et al., 2017) , demonstrating the reversal to wild-type receptor levels caused by reduced Plum. Unlike its effect on evoked response and distribution of mEJC amplitudes, muscle-specific Plum suppression alone was unable to further reduce the GluRIIA cluster area. The lack of perfect correlation between electrophysiological analyses and antibody staining likely occurred because the latter cannot distinguish between functional and non-functional glutamate receptors. Down-regulation of Plum and/or MYO in the muscle had no effect on the size of NMJ boutons (Fig. 2C) , suggesting that the density of GluR clusters did not depend on spatial constraints within boutons.
Our immuno-staining data confirm the negative effect of Plum down-regulation on enhanced neurotransmission caused by muscle-specific knock-down of MYO. 
The number of Brp puncta scales with NMJ size upon Plum and/or MYO attenuation
Bruchpilot (Brp) is a presynaptic marker at the larval NMJ and the Drosophila homolog of the vertebrate active zone protein ELKS (Wagh et al., 2006) . Brp is required for function and structural integrity of synaptic active zones and is necessary for normal evoked, but not spontaneous, release at the glutamatergic synapse of the NMJ (Wagh et al., 2006) .
We have previously shown that enhanced evoked response in reduced MYO background correlates with the increase in the NMJ size (Augustin et al., 2017) . These findings agree with the previously established positive correlation between the number of boutons and the strength of evoked signal transmission (Sigrist et al., 2003; Sigrist et al., 2002) . While the number of active zones (measured as the number of distinct Brp puncta) per bouton is unchanged between genotypes ( Figs. 3A-B) , the reversal of the increased amplitude of evoked synaptic responses in reduced MYO larvae upon Plum suppression (Fig. 1B) could be explained by the reduced bouton number, NMJ branching, and NMJ length (Fig. 3C) in the larvae suppressing both MYO and Plum.
In addition, Plum likely exhibits a broader, non-Brp related, physiological effect because the morphological changes alone cannot explain the negative effect of Plum knock-down on synaptic strength in the control background (green bar in Fig. 1B) . These findings implicate Plum as a modulator of synaptic strength in low MYO background via its impact on NMJ morphology.
Knock-down of Plum abolishes the effect of reduced MYO on muscle size and body weight
Muscle-derived MYO negatively regulates larval weight and muscle size (Augustin et al., 2017) .
We examined the effect of Plum attenuation on the size of body-wall muscles 6 and 7 ( Fig. 4A) and on total larval body weight in reduced MYO background. Plum suppression completely abolished the positive effect of MYO down-regulation on the combined area of muscles 6 and 7 ( Fig. 4B) and on larval wet weight (Fig. 4C) , mirroring its effects on synaptic physiology (Fig. 1) , synaptic composition ( Fig. 2B) and NMJ morphology (Fig. 3C) . The interaction between MYO and Plum down-regulation was significant, indicating a combinatorial effect of these interventions in abolishing the positive effect of reduced MYO on muscle size and body weight (two-way ANOVA analysis in Figs. 4C-D) . Furthermore, Plum has an independent effect on body mass, because Plum knock-down larvae exhibit significantly reduced wet weight (Fig. 4C, green bar) .
These experimental results identify Plum as a critical modulator of the action of MYO on the neuromuscular physiology, muscle size and weight, and as an independent regulator of synaptic strength and body weight in developing D. melanogaster. 
DISCUSSION
Chemical transmission across the neuromuscular junction is critical for converting action potentials originating in the central nervous system into contractile activity in skeletal muscles. It is therefore not surprising that impairment of the NMJ, in many cases, leads to reduced muscle mass and function in both vertebrates and invertebrates (Augustin and Partridge, 2009; Tintignac et al., 2015) . In addition to motor unit elimination (Piasecki et al., 2016) , reduced motor axon conduction velocity (Metter et al., 1998) , diminished motor cortex excitability (Clark et al., 2014; Oliviero et al., 2006) , and modified activity of muscle-intrinsic factors (Proctor et al., 1998) , NMJ dysfunction is strongly correlated with decreased skeletal muscle size and strength under both healthy and pathological conditions (Pratt et al., 2015) . For example, recent studies suggested that the malfunction of the NMJ plays a causative role in the onset of sarcopenia (Butikofer et al., 2011) , and proposed NMJ stabilisation as a way to delay its progression (Mori et al., 2014) . In dystrophic mdx mice, both pre-and post-synaptic abnormalities in the NMJ contribute to reduced muscle contractility (Pratt et al., 2015) and therapeutic approaches that specifically target NMJs have been proposed for treating spinal muscular atrophy and, possibly, ALS (Boido and Vercelli, 2016) .
Several mammalian proteins have identified roles in linking structural and functional properties of the NMJ and (skeletal) muscles, the most important being Agrin and MuSK (neither of which has an obvious homolog in D. melanogaster). A cleaved fragment of the proteoglycan Agrin was identified as a marker for the diagnosis of sarcopenia (Hettwer et al., 2013) and implicated in the pathogenesis of sarcopenia caused by degeneration of the NMJ . Degradation of Agrin results in structural changes in the NMJ and innervated muscles, consistent with the notion that impaired NMJ functionality plays a role in the onset of sarcopenia (Butikofer et al., 2011) . Agrin was first discovered as a neurotrophic factor sufficient for pre-and post-synaptic NMJ assembly and stabilisation (Bezakova and Ruegg, 2003) and aggregation of the junctional acetylcholine receptors (AChRs) (Ferns et al., 1993) . The clustering of AChRs and postsynaptic differentiation is initiated by the release of Agrin from the innervating motor axon, which in turn activates muscle-expressed tyrosine kinase MuSK (Muscle-specific kinase) (DeChiara et al., 1996) .
Reduced function and density of synaptic AChRs at the NMJ is a hallmark of "normal" human (Oda, 1984) and rodent (Li et al., 2011) ageing muscles, and of several NMJ disorders characterised by skeletal muscle loss and weakness (Kong et al., 2009; Querol and Illa, 2013; Xu and Salpeter, 1997) . These findings underline the importance of investigating links between the NMJ and muscle function and searching for novel regulators of these processes.
Just like Agrin, Drosophila MYO is a secreted ligand that regulates nervous system development (Awasaki et al., 2011) and NMJ synaptogenesis (Augustin et al., 2017) . While MYO of glial origin governs remodelling of mushroom body neurons in developing animals (Awasaki et al., 2011) , muscle-derived MYO functions as strong negative regulator of the size of larval somatic muscles and NMJ size and function (Augustin et al., 2017; Yu et al., 2013) . In this study, we expanded our investigation of the role MYO in the larval neuromuscular system by analysing its interaction with Plum, a trans-membrane protein recently found to modulate MYO signalling during mushroom body development (Yu et al., 2013) . Specifically, Plum sequestrates MYO, inhibiting its pruningpromoting effect on mushroom body neurons, with the reduction of endogenous Plum stimulating pruning (Yu et al., 2013) . The "low MYO" animals used in our experiments have the Myo transcript levels reduced by ~60% (Augustin et al., 2017) , with the remaining circulating MYO possibly sequestered by Plum. De-sequestering this Plum-bound MYO could therefore reverse some of the effects of genetic MYO attenuation on NMJ function and muscle size. In agreement with this hypothesis, simultaneous MYO and Plum suppression in the muscle completely reversed the effect of reduced MYO on synaptic physiology, muscle size, and total body weight. In addition, Plum reduction alone (i.e. without concomitant down-regulation of MYO) reduced the synaptic strength and body weight below control levels ( Fig. 5) , identifying muscle-derived Plum as a novel and independent target for manipulating neuromuscular function. It is important to note that MYO and Plum regulate physiological properties of the NMJ synapse by controlling the number of glutamate receptors, the functional analogues of ACh receptors in mammalian NMJs.
Sequestration is a well-described mechanism for the regulation of TGF-β ligands, with specific components of the extracellular matrix known to segregate secreted cytokines to either inhibit TGF-β signalling or concentrate the ligands for future use (Horiguchi et al., 2012) . Sequestration of TGF-β ligands was also demonstrated in Drosophila (Haerry, 2010) and proposed to facilitate autocrine TGF-β signalling in the larval NMJ (Kim and O'Connor, 2014) . Further studies are required to firmly establish this mode of ligand control in regulating the Drosophila neuromuscular system. Considering the important role of TGF-β ligands in the regulation of muscle mass and NMJ function in mammalian model species (Fong et al., 2010; McLennan and Koishi, 1994) and in humans (Chen et al., 2016; McLennan and Koishi, 2002) , these findings can point to novel mechanism for therapeutic interventions in pathologies associated with ageing and neuromuscular disorders.
MATERIALS AND METHODS
Fly stocks and husbandry
All stocks were maintained and all experiments were conducted at 25°C on a 12 h:12 h light:dark cycle at constant humidity using standard sugar/yeast/agar (SYA) media (15 g/l agar, 50 g/l sugar, 100 g/l autolyzed yeast, 100 g/l nipagin and 3 ml/l propionic acid) (Bass et al., 2007) . Third instar wandering larvae used in the experiments were selected based on morphological (larval spiracles and mouth-hook) and behavioural criteria (location outside of the food). Tissue-specific expression was achieved with the GAL4-UAS system [GAL4-dependant upstream activator sequence] (Brand and Perrimon, 1993) . Drosophila stocks used were: UAS-miRNAmyo ( 
NMJ electrophysiology
Recordings were performed as described previously (Robinson et al., 2014) . Two-electrode voltage clamp (TEVC) recordings using sharp electrodes were made from ventral longitudinal muscle 6 in abdominal segments 2-4 of wandering third instar larvae. NMJ recordings were performed using pClamp 10, an Axoclamp 900A amplifier and Digidata 1440A (Molecular Devices, USA) in haemolymph-like 3 (HL-3) solution: 70 mM NaCl, 5 mM KCl, 20 mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 5 mM trehalose, 5 mM HEPES and 2 mM CaCl2. Recording electrodes (10-30 MΩ) were filled with 3 M KCl. Miniature excitatory junctional currents (mEJCs) were recorded in the presence of 0.5 μM tetrodotoxin (Tocris, UK). All synaptic responses were recorded from muscles with input resistances ≥4 MΩ and resting potentials more negative than −60 mV at 25°C as differences in recording temperature cause changes in glutamate receptor kinetics and amplitudes (Postlethwaite et al., 2007) . Holding potentials were -60 mV. Mean single eEJC amplitudes (stimulus: 0.1 ms, 1-5 V) are based on the mean peak eEJC amplitude in response to ten presynaptic stimuli (recorded at 0.2 Hz). Nerve stimulation was performed with an isolated stimulator (DS2A, Digitimer). The data were digitized at 10 kHz and for miniature recordings, 200 s recordings were analysed to obtain mean mEJC amplitudes and frequency values. mEJC and eEJC recordings were off-line low-pass filtered at 500 Hz and 1 kHz, respectively. Materials were purchased from Sigma-Aldrich (UK) unless otherwise stated.
Immunocytochemistry and confocal microscopy
Immunocytochemistry and confocal microscopy were performed as described previously (Augustin et al., 2017) using Zeiss 700 inverted confocal microscope. All neuromuscular junction (NMJ) images and analyses were from NMJs on larval ventral longitudinal muscles 6 and 7 (hemi-segments A3-A4).
For glutamate receptor (GluRIIA) and Brp staining, 3 rd instar larval preparations were dissected in modified HL-3 solution and fixed for 30 min in Bouin's fixative. Mouse monoclonal anti-GluRIIA (8B4D2) and anti-Brp (nc82) antibodies were obtained from the University of Iowa Developmental Studies Hybridoma Bank (Iowa City, USA) and used at 1:100 and 1:20, respectively. AlexaFluorconjugated goat anti-mouse secondary antibodies were used at 1:200. TRITC-labeled antihorseradish peroxidase (HRP) antibody (staining neuronal membranes) was used at 1:100. To visualize larval muscles, phalloidin was added to fresh larval preparations fixed for 30 min with 4% paraformaldehyde. Measurements of the postsynaptic glutamate receptors were made using ImageJ by drawing a circle around individual GluRIIA clusters in type Ib synaptic boutons.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5 software. For comparisons between two or more groups, a one-way ANOVA followed by a Tukey-Kramer test was used. In all instances, P<0.05 is considered statistically significant (*P<0.05; **P<0.01; ***P<0.001). Values are reported as the mean ± SEM. A 2-way ANOVA test was used to perform interaction calculations. The Kolmogorov-Smirnov (KS) test was used to analyse the cumulative distribution of mEJC amplitudes.
